amyloid

New Alzheimer’s Drugs Don’t Deserve the Hype – Here’s Why

As US FDA Approves New Drug for Alzheimer’s, Scientists Flag Safety Concerns

Alzheimer’s Research in Turmoil as Sleuths Cast Doubt on Field-Defining Paper

The Powerful Case for Redefining Alzheimer’s Disease